A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Clinical trial NCT00505414 · TERMINATED
Trial details
- NCT number
- NCT00505414
- Sponsor
- Grünenthal GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-02-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.